Cadila Healthcare SWOT Analysis, Competitors, STP & USP
SWOT analysis of Cadila Healthcare analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Cadila Healthcare SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
SWOT Analysis is a proven management framework which enables a brand like Cadila Healthcare to benchmark its business & performance as compared to the competitors and industry. Cadila Healthcare is one of the leading brands in the pharma and healthcare sector.
The table below lists the SWOT (Strengths, Weaknesses, Opportunities, Threats), top Cadila Healthcare competitors and includes Cadila Healthcare target market, segmentation, positioning & Unique Selling Proposition (USP).
| Cadila Healthcare Brand Analysis | |
|---|---|
| Parent Company |
Cadila Healthcare |
| Category |
Pharmaceuticals |
| Sector | |
| Tagline/ Slogan |
The care continues |
| USP |
An integrated healthcare solutions provider, catering to over 45 therapeutic segments. |
| Cadila Healthcare STP | |
| Cadila Healthcare Segmentation |
Respiratory agents, cardiovascular, haematinics, gastrointestinal, analgesics, anti-infective and antibiotics, anti- diabetics and immunological. |
| Cadila Healthcare Target Market |
Diagnostic, preventive and curative pharmaceutical and diagnostic product seeking healthcare professionals |
| Cadila Healthcare Positioning |
Marketing of the pharma products to assuage, identify and thwart diseases. |
| Cadila Healthcare SWOT Analysis | |
| Cadila Healthcare Strengths |
Below are the Strengths in the SWOT Analysis of Cadila Healthcare: 1.USFDA approved plant for clinical trials 2.Sole manufacturer in Indian of Streptokinase and Hyaluronic Acid-based products 3. Caters to over 45 therapeutic areas and has presence in over 90 countries 4. Cadila has acquired Bio-chem which is major player in anti-infective segment in domestic market 5. Recommercialisation of Urokinase through partnership with Microbix |
| Cadila Healthcare Weaknesses |
Here are the weaknesses in the Cadila Healthcare SWOT Analysis: 1. Tough competition means the market share is limted 2. Weak international presence compared to a few international brands |
| Cadila Healthcare Opportunities |
Following are the Opportunities in Cadila Healthcare SWOT Analysis: 1. Large penetration strategies in the therapeutic market to increase the market share 2. increasing prevalence of chronic diseases such as diabetes, cancer 3. Penetration of medical insurance |
| Cadila Healthcare Threats |
The threats in the SWOT Analysis of Cadila Healthcare are as mentioned: 1. Debt in the foreign currency and weak rupee may cause MTM 2. Economic fluctuations and emergence of global players |
| Cadila Healthcare Competition | |
| Competitors |
Below are the top 5 Cadila Healthcare competitors: 1. Sun Pharma 3. Cipla 4. Lupin 5. Ranbaxy |
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Cadila Healthcare. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2800 brands from over 20 industry sectors.
Search & Explore : SWOT Analysis
Edit the brand or add a new one to SWOT Analysis section : Contribute
